UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
April 25, 2007 4:30 P.M.
Form:
S-1
CIK:
0001382911
Company Name:
Orexigen Therapeutics, Inc.
File Number:
333-139496